The NAVICA™ app is your pass to navigating daily life in a new normal. NAVICA displays results from the 15-minute Abbott BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, to help you and others make informed decisions.
Organizations will be able to view and verify a person's digital NAVICA Pass on their mobile device to facilitate smoother entry into facilities along with handwashing, social distancing, enhanced cleaning and mask-wearing.
Creating an account in NAVICA enables you to get results sent to your smartphone from your test provider after you get tested using the 15-minute Abbott BinaxNOW™ COVID-19 Ag Card, a rapid antigen test, at a NAVICA enabled testing site. People who receive a negative test result will get a digital NAVICA Pass with a QR code, similar to an airline boarding pass, that you can easily display. Organizations can view and verify this pass to facilitate entry into facilities along with handwashing, social distancing, enhanced cleaning and mask-wearing in order to help control further spread of the virus.
With NAVICA you can:
Visit NAVICA.ABBOTT to sign up to be one of the first to know when and where the COVID-19 tests are being offered in your community.
NAVICA will display a digital NAVICA Pass via a QR code, similar to an airline boarding pass, for the NAVICA user who has received a negative result from a NAVICA-enabled test site. This allows organizations to verify negative test results, enabling people to move about with greater confidence, or see a positive test result and request that the person self-quarantine to avoid infecting others.
Getting a NAVICA pass is an easy 3-step process:
The BinaxNOW COVID-19 Ag Card is a rapid lateral flow antigen test administered by a healthcare professional or a trained operator. It tests for active infection using a direct nasal swab. It provides a positive or negative result in 15 minutes with no instrument required.
Abbott is offering BinaxNOW COVID-19 Ag Card tests to organizations with staff qualified to deliver COVID-19 testing. We are currently working with the U.S. Department of Health and Human Services and its identified recipients on the distribution of the BinaxNOW™ COVID-19 Ag Card. If you are at one of these institutions, you may receive further instructions. Individuals looking for BinaxNOW tests can visit NAVICA.ABBOTT to sign up to be one of the first to know when and where these tests are being offered in your community.
Abbott is offering the mobile app at no charge.
The information needed to create your NAVICA ID is First Name, Last Name, Address, Email Address, Date of Birth and mobile phone number. We also collect race, gender, ethnicity, and participant type in the NAVICA app for US state and government agencies which require we request this information for tracking purposes. Anyone who is tested for COVID-19 is required to provide certain information, which is required to be reported to departments of health, so you should expect to be asked to share additional information about yourself when you get tested.
Check your email account junk mail or spam filters for email verification code. You can resend the email or chose a different email address during the sign-up process if you do not receive it.
You can change your password from the sign-in screen with the 'Forgot my password' link. You'll be asked to verify your email address again to proceed with changing your password.
iOS devices now allow you to edit your information within the app. Visit Account and Settings, then click ‘Edit Profile’. If you do not see this option, visit the App Store to ensure you are on the latest app version. Edit profile is not yet available on Android devices, but that capability is coming in an app update soon.
We recommend you update your app to the latest version available in Google Play. This new version (1.6 or later) enables you to type your birthday instead of selecting it in a calendar view.
Our technical services team can be reached Monday to Friday 8AM to 8PM Eastern Standard Time at (800) 257-9525. Please have the following information available so we can best assist you: phone type, phone operating version, and app version.
The BinaxNOW™ COVID-19 Ag Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.